ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT03402880 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients enrolled

Conditions

Extensive Stage Small Cell Lung Carcinoma

Interventions

BIOLOGICAL: Pembrolizumab
DRUG: Epacadostat
OTHER: Laboratory Biomarker Analysis

Sponsor

City of Hope Medical Center

Collaborators

[object Object]